Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - The Lancet …, 2018 - thelancet.com
Background Improved understanding is needed of risk factors and markers of disease
progression in preclinical Alzheimer's disease. We assessed associations between brain β …
被引用次数：223 相关文章

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse… - The Lancet …, 2018 - hal.sorbonne-universite.fr
Improved understanding is needed of risk factors and markers of disease progression in
preclinical Alzheimer's disease. We assessed associations between brain β-amyloidosis …

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse… - The Lancet …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Improved understanding is needed of risk factors and markers of disease
progression in preclinical Alzheimer's disease. We assessed associations between brain β …

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - LANCET …, 2018 - arpi.unipi.it
Background: Improved understanding is needed of risk factors and markers of disease
progression in preclinical Alzheimer's disease. We assessed associations between brain β …
[PDF] academia.edu

[PDF][PDF] Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - academia.edu
Background-. A better understanding is needed concerning the risk factors and markers of
disease progression in preclinical AD. In the Investigation of Alzheimer's Predictors in …

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - The Lancet …, 2018 - hal.science
Improved understanding is needed of risk factors and markers of disease progression in
preclinical Alzheimer's disease. We assessed associations between brain β-amyloidosis …

[引用][C] Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - The Lancet …, 2018 - cir.nii.ac.jp
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of
Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study | CiNii Research CiNii …

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): A longitudinal observational study.

B Dubois, S Epelbaum, F Nyasse… - The Lancet …, 2018 - psycnet.apa.org
Abstract [Correction Notice: An Erratum for this article was reported in Vol 17 (6) of The
Lancet Neurology (see record 2018-24983-012). In the original article, the second line of the …

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - The Lancet …, 2018 - Elsevier
Background Improved understanding is needed of risk factors and markers of disease
progression in preclinical Alzheimer's disease. We assessed associations between brain β …

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study

B Dubois, S Epelbaum, F Nyasse, H Bakardjian… - The Lancet …, 2018 - thelancet.com
Background Improved understanding is needed of risk factors and markers of disease
progression in preclinical Alzheimer's disease. We assessed associations between brain β …